BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28939229)

  • 1. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
    Waddle MR; Sio TT; Van Houten HK; Foote RL; Keole SR; Schild SE; Laack N; Daniels TB; Crown W; Shah ND; Miller RC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1078-1082. PubMed ID: 28939229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis.
    Pan HY; Jiang J; Shih YT; Smith BD
    J Am Coll Radiol; 2017 Aug; 14(8):1027-1033.e2. PubMed ID: 28408078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy.
    Gunther JR; Sato M; Chintagumpala M; Ketonen L; Jones JY; Allen PK; Paulino AC; Okcu MF; Su JM; Weinberg J; Boehling NS; Khatua S; Adesina A; Dauser R; Whitehead WE; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):54-63. PubMed ID: 26279024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.
    Xiang M; Chang DT; Pollom EL
    Cancer; 2020 Aug; 126(15):3560-3568. PubMed ID: 32426866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
    Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC
    Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.
    Pan HY; Jiang J; Hoffman KE; Tang C; Choi SL; Nguyen QN; Frank SJ; Anscher MS; Shih YT; Smith BD
    J Clin Oncol; 2018 Jun; 36(18):1823-1830. PubMed ID: 29561693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
    Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best way to radiate the prostate in 2016?
    Moon DH; Efstathiou JA; Chen RC
    Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy for prostate cancer-a review.
    Haque W; Butler EB; Teh BS
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
    Kamran SC; Light JO; Efstathiou JA
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric radiation oncology in Germany: a study of availability and application.
    Bölling T; Ernst I; Könemann S; Willich N
    Klin Padiatr; 2008; 220(3):178-82. PubMed ID: 18478491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
    Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
    J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic factors affect the selection of proton radiation therapy for children.
    Shen CJ; Hu C; Ladra MM; Narang AK; Pollack CE; Terezakis SA
    Cancer; 2017 Oct; 123(20):4048-4056. PubMed ID: 28654202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.